Article

Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS

2020-04-30

Abstract excerpt

The COVID-19 pandemic caused by the novel SARS-CoV-2 is more contagious than other coronaviruses and has higher rates of mortality than influenza. As no vaccine or drugs are currently approved to specifically treat COVID-19, identification of effective therapeutics is crucial to treat the afflicted and limit disease spread. We deployed a bioinformatics workflow to identify candidate drugs for the treatment of COVI...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1e1d3e20-7278-5e9c-9ce3-9a424f898178
DOI: 10.21203/rs.3.rs-25643/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCSDOI 10.21203/rs.3.rs-25643/v1Read

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSemantic proximity Read

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19Semantic proximity Read

Modeling COVID-19 disease biology to identify drug treatment candidatesSemantic proximity Read

Network bioinformatics analysis provides insight into drug repurposing for COVID-19Semantic proximity Read

Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug ArsenalSemantic proximity Read

In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic DataSemantic proximity Read

Large Scale Profiling of SARS-CoV-2-Infected Patients Identified Potential Therapeutic Host Targets and Drug Candidates for COVID-19Semantic proximity Read

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachSemantic proximity Read

Drug Repurposing of potential drug targets for treatment of COVID-19Semantic proximity Read

A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity Read

A signaling pathway-driven bioinformatics pipeline for predicting therapeutics against emerging infectious diseasesSemantic proximity Read

Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug ArsenalSemantic proximity Read